The store will not work correctly when cookies are disabled.
(5-Amino-3-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)(cyclohexyl)-methanone
ID: ALA4756713
PubChem CID: 162655757
Max Phase: Preclinical
Molecular Formula: C14H17N5O
Molecular Weight: 271.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1nc(-c2ccncc2)n[nH]1)C1CCCCC1
Standard InChI: InChI=1S/C14H17N5O/c20-13(11-4-2-1-3-5-11)17-14-16-12(18-19-14)10-6-8-15-9-7-10/h6-9,11H,1-5H2,(H2,16,17,18,19,20)
Standard InChI Key: FHNMKTHKWQBUHT-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
27.6458 -9.0339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2981 -8.5361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0267 -7.7611 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2031 -7.7825 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9702 -8.5702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0855 -8.7688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1960 -8.8437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5778 -8.3123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8042 -8.5852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6513 -9.3937 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.2822 -9.9288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0533 -9.6490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6829 -8.2026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4704 -8.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4886 -7.4037 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6546 -9.2369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4381 -9.4704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0386 -8.9071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8460 -8.1068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0570 -7.8699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
2 6 1 0
5 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
6 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
14 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 271.32 | Molecular Weight (Monoisotopic): 271.1433 | AlogP: 2.39 | #Rotatable Bonds: 3 |
Polar Surface Area: 83.56 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.29 | CX Basic pKa: 2.94 | CX LogP: 2.75 | CX LogD: 2.70 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.90 | Np Likeness Score: -1.96 |
References
1. Korff M,Imberg L,Will JM,Bückreiß N,Kalinina SA,Wenzel BM,Kastner GA,Daniliuc CG,Barth M,Ovsepyan RA,Butov KR,Humpf HU,Lehr M,Panteleev MA,Poso A,Karst U,Steinmetzer T,Bendas G,Kalinin DV. (2020) Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action., 63 (21): [PMID:33089691] [10.1021/acs.jmedchem.0c01635] |